Newsroom

The voting process will be opened until July 21 2024. You still have time to cast your vote using your LinkedIn account. You can vote for...

In a fascinating episode of the X-Health.show podcast, Ana Montalban-Arques, CEO of Recolony, discusses the potential of gut microbiota...

Our CEO, Ana Montalban-Arques, had a conversation with FOUNDED, where she explained the innovative bacteria-based cancer therapy that is...

Ana Montalban-Arques, was recently featured on the Swisspreneur podcast, where she discussed our bacteria-based cancer therapy and shared...

As part of the JP Morgan week, Philipp will present the latest advances in our bacteria-based cancer therapy. This is a great opportunity...

As part of the Technology Showcase, Ana will present the latest advances of Recolony.

Our CBO, Philipp Busenhart, will be representing Recolony the next 7th of November in Munich.

Recolony ranks 10th in this annual ranking created by 100 leading investors and industry experts of the Swiss Startup scene.

Recolony enters the prestigious Top100 Swiss Startups ranking as newcomer in its first year of existence. The TOP 100 Swiss Startup Award...

Philipp Busenhart, CBO of Recolony, presents our company in this interview with the Handelzeitung

Recolony wins the Stage III of Venture Kick. Recolony will invest the CHF 150,000 awarded by Venture Kick to advance our small molecule...

Recolony has been nominated as Newcomer of the Year (Startup) by Viktor- The Swiss Healthcare Awards. Five Swiss startups have been...

We’ve been named one of Hello Tomorrow's Deep Tech Pioneers! Come and meet us at the Hello Tomorrow Global Summit 2023, March 9-10th in...

The InnoBooster program from Gebert Rüf Stiftung aims at speeding up innovative, science-based deep tech businesses which have already...

SWICA September Newsletter includes an article about Recolony Source: Swiss.ch

Recolony has been selected to be part of the Swiss National Startup Team 2022 and will join Venture Leaders Biotech next September in...

Recolony wins Venture Kick Stage II and receives additional 40.000 CHF to support the development of our bacteria-based cancer therapy....

Recolony has successfully get into the Stage I of Venture Kick About Venture Kick: Venture Kick is a philanthropic three stage funding...

Ana Montalban-Arques got interviewed by the University of Zurich to talk about our bacteria-based cancer therapy for the treatment of...

Recolony was chosen as finalist in the >>venture>> startup competition. On the 19th of May we will pitch in the final and compete against...

Recolony is selected to participate in the pitching competition during the Swiss Microbiomes Forum organized by NCCR Microbiomes, the 6th...

Come and hear our CEO Ana Montalban-Arques , speak about "Commensal Bacteria as Stand-alone Therapy for Colorectal Cancer". About the...

Recolony receives support from the USZ Health Innovation Hub to advance their bacteria-based cancer therapy. The Health Innovation Hub is...